Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The Tumor Microenvironment Modulates Choline and Lipid Metabolism
Noriko Mori, Flonné Wildes, Tomoyo Takagi, et al.
Frontiers in Oncology (2016) Vol. 6
Open Access | Times Cited: 50

Showing 1-25 of 50 citing articles:

Phosphatidylcholine-Derived Lipid Mediators: The Crosstalk Between Cancer Cells and Immune Cells
Renata de Freitas Saito, Luciana Nogueira de Sousa Andrade, Silvina Odete Bustos, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 109
Biomarkers in Cancer Detection, Diagnosis, and Prognosis
Sreyashi Das, Mohan Kumar Dey, Ram V. Devireddy, et al.
Sensors (2023) Vol. 24, Iss. 1, pp. 37-37
Open Access | Times Cited: 93
Acetylcholine signaling system in progression of lung cancers
Jamie R. Friedman, Stephen D. Richbart, Justin C. Merritt, et al.
Pharmacology & Therapeutics (2018) Vol. 194, pp. 222-254
Open Access | Times Cited: 96
Insights into molecular mechanisms of chemotherapy resistance in cancer
Animesh Kar, Shivam Agarwal, Agrata Singh, et al.
Translational Oncology (2024) Vol. 42, pp. 101901-101901
Open Access | Times Cited: 12
Transcending frontiers in prostate cancer: the role of oncometabolites on epigenetic regulation, CSCs, and tumor microenvironment to identify new therapeutic strategies
Giulia Ambrosini, Marco Cordani, Ali Zarrabi, et al.
Cell Communication and Signaling (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 10
Benchmarking to the Gold Standard: Hyaluronan‐Oxime Hydrogels Recapitulate Xenograft Models with In Vitro Breast Cancer Spheroid Culture
Alexander E. G. Baker, Laura C. Bahlmann, Roger Y. Tam, et al.
Advanced Materials (2019) Vol. 31, Iss. 36
Open Access | Times Cited: 69
Stimulus-responsive nanoscale delivery systems triggered by the enzymes in the tumor microenvironment
Zhentao Zhang, Ming-Yi Huang-Fu, Wenhong Xu, et al.
European Journal of Pharmaceutics and Biopharmaceutics (2019) Vol. 137, pp. 122-130
Closed Access | Times Cited: 62
Advanced Magnetic Resonance Imaging Techniques in Management of Brain Metastases
Hatef Mehrabian, Jay Detsky, Hany Soliman, et al.
Frontiers in Oncology (2019) Vol. 9
Open Access | Times Cited: 58
Advanced Imaging of Brain Metastases: From Augmenting Visualization and Improving Diagnosis to Evaluating Treatment Response
Elizabeth Tong, Kassie Lyn McCullagh, Michael Iv
Frontiers in Neurology (2020) Vol. 11
Open Access | Times Cited: 58
Magnetic Resonance Imaging (MRI) and MR Spectroscopic Methods in Understanding Breast Cancer Biology and Metabolism
Uma Sharma, N. R. Jagannathan
Metabolites (2022) Vol. 12, Iss. 4, pp. 295-295
Open Access | Times Cited: 30
Molecular effects of clinically relevant chemotherapeutic agents on choline phospholipid metabolism in triple negative breast cancer cells
Caitlin M. Tressler, Kanchan Sonkar, Menglin Cheng, et al.
Translational Oncology (2025) Vol. 53, pp. 102311-102311
Closed Access
Analysis of microarray and single-cell RNA-seq identifies gene co-expression, cell–cell communication, and tumor environment associated with metabolite interconversion enzyme in prostate cancer
Danial Hashemi Karoii, Ali Abroudi, Nadia Forghani, et al.
Discover Oncology (2025) Vol. 16, Iss. 1
Open Access
Exploring Metabolic Shifts in Kidney Cancer and Non-Cancer Cells Under Pro- and Anti-Apoptotic Treatments Using NMR Metabolomics
Lucia Trisolini, Biagia Musio, Bruno Bastos Teixeira, et al.
Cells (2025) Vol. 14, Iss. 5, pp. 367-367
Open Access
Ascites Volumes and the Ovarian Cancer Microenvironment
Marie‐France Penet, Balaji Krishnamachary, Flonné Wildes, et al.
Frontiers in Oncology (2018) Vol. 8
Open Access | Times Cited: 43
Intracellular Restructured Reduced Glutathione-Responsive Peptide Nanofibers for Synergetic Tumor Chemotherapy
Wang-Wei Guo, Zhentao Zhang, Qichun Wei, et al.
Biomacromolecules (2019) Vol. 21, Iss. 2, pp. 444-453
Closed Access | Times Cited: 36
Breast Tissue Metabolism by Magnetic Resonance Spectroscopy
N. R. Jagannathan, Uma Sharma
Metabolites (2017) Vol. 7, Iss. 2, pp. 25-25
Open Access | Times Cited: 39
Metabolism of prostate cancer by magnetic resonance spectroscopy (MRS)
Uma Sharma, N. R. Jagannathan
Biophysical Reviews (2020) Vol. 12, Iss. 5, pp. 1163-1173
Open Access | Times Cited: 24
Inhibiting the glycerophosphodiesterase EDI3 in ER-HER2+ breast cancer cells resistant to HER2-targeted therapy reduces viability and tumour growth
Magdalena Keller, Katharina Rohlf, Annika Glotzbach, et al.
Journal of Experimental & Clinical Cancer Research (2023) Vol. 42, Iss. 1
Open Access | Times Cited: 8
Geriatric nutritional risk index is not an independent predictor in patients with diffuse large B-cell lymphoma
Zhongqi Li, Qi Guo, Juying Wei, et al.
Cancer Biomarkers (2018) Vol. 21, Iss. 4, pp. 813-820
Closed Access | Times Cited: 26
Dietary Choline Supplementation Attenuates High-Fat-Diet–Induced Hepatocellular Carcinoma in Mice
Amanda L. Brown, Kelsey Conrad, Daniela Allende, et al.
Journal of Nutrition (2019) Vol. 150, Iss. 4, pp. 775-783
Open Access | Times Cited: 20
Metabolic biomarkers of response to the AKT inhibitor MK-2206 in pre-clinical models of human colorectal and prostate carcinoma
Nada M.S. Al-Saffar, Helen Troy, Anne-Christine Wong Te Fong, et al.
British Journal of Cancer (2018) Vol. 119, Iss. 9, pp. 1118-1128
Open Access | Times Cited: 15
Evaluation of Aflatoxin M1 Effects on the Metabolomic and Cytokinomic Profiling of a Hepatoblastoma Cell Line
Silvia Marchese, Angela Sorice, Andrea Ariano, et al.
Toxins (2018) Vol. 10, Iss. 11, pp. 436-436
Open Access | Times Cited: 13
BRD9 status is a major contributor for cysteine metabolic remodeling through MST and EAAT3 modulation in malignant melanoma
Ana Hipólito, Renato Xavier, Cheila Brito, et al.
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease (2023) Vol. 1870, Iss. 2, pp. 166983-166983
Open Access | Times Cited: 4
EDI3 knockdown in ER-HER2+ breast cancer cells reduces tumor burden and improves survival in two mouse models of experimental metastasis
Annika Glotzbach, Katharina Rohlf, Anastasia Gonscharow, et al.
Breast Cancer Research (2024) Vol. 26, Iss. 1
Open Access | Times Cited: 1
Relevance of emerging metabolomics-based biomarkers of prostate cancer: a systematic review
Navneeta Bansal, Manoj Kumar, Satyanarayan Sankhwar, et al.
Expert Reviews in Molecular Medicine (2022) Vol. 24
Closed Access | Times Cited: 7
Page 1 - Next Page

Scroll to top